1st Quarter - Termination Amendment — DALRYMPLE & ASSOCIATES, LLC for PULMATRIX, INC. (2011)

Firm

DALRYMPLE & ASSOCIATES, LLC

Client

PULMATRIX, INC.

Income

—

Expenses

—

Terminated

Nov 15, 2010

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Appropriations and funding under federal government contracts for development of broad spectrum products and delivery systems for the prevention, prophylaxis, treatment and halting transmission of infectious respiratory diseases.

Lobbyist	Covered position, as disclosed
DONALD DALRYMPLE	Principal and Managing Director

Contacted: Defense Advanced Research Projects Agency (DARPA); HOUSE OF REPRESENTATIVES; SENATE; State, Dept of (DOS); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Defense Threat Reduction Agency (DTRA); Homeland Security, Dept of (DHS); Army, Dept of (Other); Government Accountability Office (GAO); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Defense, Dept of (DOD)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.